Home / Germany / Outlook Therapeutics Inc
Outlook Therapeutics Inc
Short position disclosed on June 28, 2024.
Evolution of the disclosed total
June 28, 2024 today
Open positions
| Fund | Twelve months | % of capital | Over the year | Since |
|---|---|---|---|---|
| Bronte Capital Management Pty Ltd | 0.59% | unchanged | June 28, 2024 |
In the United States OTLK (Nasdaq): 32,910,138 shares sold short on August 31, 2026. FINRA names no fund.
On the other side: the funds that hold Outlook Therapeutics Inc Titelia
Get the moves on Outlook Therapeutics Inc by mail.
No account: one address, one link to confirm, one link to stop in every message.
History of disclosures
| Date | Fund | % of capital | End of publication |
|---|---|---|---|
| June 28, 2024 | Bronte Capital Management Pty Ltd | 0.59% | still open |
Download 1 filing as CSV Columns: Date, Fund, Market, Disclosed position, Unit, End date. The other formats
Other companies sold short in Germany
- TUI AG 8.56% of the capital sold short
- HelloFresh SE 7.84% of the capital sold short
- AUTO1 Group SE 7.23% of the capital sold short
- Hugo Boss AG 7.19% of the capital sold short
- Zalando SE 6.11% of the capital sold short
- Gerresheimer AG 5.99% of the capital sold short
- PVA TePla AG 5.72% of the capital sold short
- Velo3D Inc 5.72% of the capital sold short
- Cancom SE 5.55% of the capital sold short
- Evotec SE 5.41% of the capital sold short
- Puma SE 5.41% of the capital sold short
- RENK Group AG 5.31% of the capital sold short
Cite this page
The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.
QuiVad, Outlook Therapeutics Inc, source Bundesanzeiger, data as at June 28, 2024, https://www.quivad.com/action/outlook-therapeutics-inc